Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 869 of 6351
-
Low oxygen breathing boosts walking recovery in spinal cord injury trial
Symptom relief Recruiting nowThe purpose of this study is to determine how combining bouts of low oxygen, transcutaneous spinal cord stimulation, and walking training may improve walking function for people with chronic spinal cord injury.
Sponsor: Spaulding Rehabilitation Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 11:04 UTC
-
New drug duo takes on multiple cancers in Mid-Stage trial
Disease control OngoingThe purpose of this study is to evaluate the efficacy and safety of combination of SKB264 and Pembrolizumab in patients with selected solid tumors including cervical cancer, urothelial cancer, ovarian cancer, prostate cancer,advanced endometrial cancer.
Phase 2 • Sponsor: Klus Pharma Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Battle of the scopes: which technique best wipes out Barrett's lesions?
Disease control Recruiting nowRationale: The optimal technique for removal of visible dysplastic lesions in Barrett's esophagus remains controversial. Endoscopic mucosal resection (EMR) is safe, effective, easy to apply, and has been the most widely used technique since 2008. Endoscopic submucosal dissection…
Sponsor: St. Antonius Hospital • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New asthma drug shows promise in reducing severe attacks
Disease control OngoingThis study is a phase 2 study of SHR-1905 in subjects with severe uncontrolled asthma. The purpose of the study is to evaluate efficacy and safety of SHR-1905 in subjects with severe uncontrolled asthma.
Phase 2 • Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Simple shower routine after colon surgery may slash infection risk
Disease control Recruiting nowThe DECREASE SSI Trial (Decolonization to Reduce After-Surgery Events of Surgical Site Infection) is a two-arm multi-center individual placebo-controlled randomized (2,700 participants randomized 1:1) clinical trial to reduce post-discharge surgical site infection following open …
Phase 4 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New pill hopes to stop UC Flare-Ups in their tracks
Disease control OngoingThis is a multicenter, randomized, placebo-controlled study to evaluate the long-term efficacy and safety of ABX464 50mg and 25mg administered once daily (QD) as maintenance therapy in subjects with moderately to severely active ulcerative colitis who have inadequate response, no…
Phase 3 • Sponsor: Abivax S.A. • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New cocktail of drugs shows promise for tough stomach cancer
Disease control Recruiting nowThis is a Phase II, open-label, multi-drug, multi-centre study designed to assess the efficacy, safety, tolerability, pharmacokinetics, and immunogenicity of novel combination therapies in participants with locally advanced unresectable or metastatic gastric or GEJ adenocarcinoma…
Phase 2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Can a smartphone VR headset distract kids from burn pain?
Symptom relief By invitation onlyThis study will evaluate the effectiveness of smartphone Virtual Reality Pain Alleviation Therapy (VR-PAT) as a pain distraction tool during repeated at-home burn dressing changes among 100 children (age 6-17 years) with a burn injury in comparison to 100 children with a burn inj…
Sponsor: Nationwide Children's Hospital • Aim: Symptom relief
Last updated Aug 02, 2026 00:00 UTC
-
Smart MRI boosts brain cancer zapping therapy
Disease control Recruiting nowThis research study is for Glioblastoma (GBM) patients who will be beginning Optune as part of their clinical care, which is a novel treatment that utilizes - tumor treating fields (TTFields), (aka, electrical therapy), which has shown to improve overall survival in large multi-c…
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New combo therapy shows promise for tough-to-treat liver cancer
Disease control CompletedThis study is investigator initiated, single-institution, prospective, phase 2 open-label study to determine the efficacy and safety of combination therapy of atezolizumab/bevacizumab and proton beam therapy to portal vein tumor thrombosis with or without main primary tumor in pa…
Phase 2 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a One-Day mindset workshop stop chronic pain after back surgery?
Prevention CompletedThe present study aims to adapt and modify a brief presurgical Acceptance and Commitment Therapy (ACT) intervention aimed at preventing the transition to Chronic Post-Surgical Pain (CPSP) and reducing long-term opioid use. Investigators will then assess the acceptability, feasibi…
Sponsor: Brigham and Women's Hospital • Aim: Prevention
Last updated Aug 21, 2026 00:00 UTC
-
Stem cells and 3D printing join forces to mend broken bones and arthritic knees
Disease control OngoingBrief Summary This clinical study investigates the safety and effectiveness of combining advanced regenerative therapies with personalized surgical technology for patients with delayed fracture healing (non-unions), knee osteoarthritis, and those requiring total knee replacement.…
Sponsor: Zaporizhzhiya State Medical University • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Could a daily pill help kids with inherited high cholesterol?
Disease control CompletedMultiple-dose study to measure pharmacokinetics, pharmacodynamics and safety of bempedoic acid in pediatric participants 6 to 17 years of age with HeFH.
Phase 2 • Sponsor: Esperion Therapeutics, Inc. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New pill could tame lupus flares
Disease control OngoingThe purpose of this study is to evaluate the effectiveness and safety of deucravacitinib compared with placebo in an active moderate to severe Systemic Lupus Erythematosus (SLE) population.
Phase 3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Can discarded bone reveal the secrets to stronger bones?
Knowledge-focused Recruiting nowDiseases of bone associated with ageing, including osteoporosis (OP) and osteoarthritis (OA), reduce bone mass, bone strength and joint integrity. Current non-surgical approaches are limited to pharmaceutical agents that are not disease modifying and have poor patient tolerabilit…
Sponsor: Relation Therapeutics • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
New eczema drug shows promise for people with darker skin
Disease control CompletedThe main purpose of this study is to determine the safety and efficacy lebrikizumab in adolescent and adult participants with moderate-to-severe atopic dermatitis (AD) and skin of color.
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Hearing aids may slow memory loss in seniors, major trial hopes
Disease control OngoingThe ACHIEVE Brain Health Follow-Up Study is a 3-year follow-up to the Aging and Cognitive Health Evaluation in Elders (ACHIEVE) randomized study to determine the long-term effect of hearing intervention vs. successful aging/delayed hearing intervention on rates of cognitive decli…
Phase 3 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New lupus pill shows promise in major trial
Disease control OngoingThe purpose of this study is to evaluate the effectiveness and safety of deucravacitinib compared with placebo in an active moderate to severe Systemic Lupus Erythematosus (SLE) population.
Phase 3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New cocktail targets rare breast cancer that defies standard treatment
Disease control Recruiting nowThis is a research study to test the safety and effectiveness of using the drug alpelisib together with chemotherapy (nab-paclitaxel) and a drug called L-NMMA in patients with HER2 negative metastatic or locally advanced metaplastic breast cancer, who have not responded to previo…
Phase 2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New daily pill could ease sickle cell pain for kids
Disease control Recruiting nowThe purpose of this study is to evaluate the pharmacokinetics and safety of etavopivat in paediatric participants with sickle cell disease (SCD). Participants will receive etavopivat and will be enrolled in a staggered manner, starting with the oldest age group and followed seque…
Phase 2 • Sponsor: Forma Therapeutics, Inc. • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC